Table of contents of journal:

Results: 76-89/89

Detection of apoptosis in ovarian cells in vitro and in vivo using the annexin V-affinity assay

Authors: van Engeland, M van den Eijnde, SM van Aken, T Vermeij-Keers, C Ramaekers, FCS Schutte, B Reutelingsperger, CPM

Citation: M. Van Engeland et al., Detection of apoptosis in ovarian cells in vitro and in vivo using the annexin V-affinity assay, METH MOL M, 39, 2000, pp. 669-677

Use of diphenylamine in the detection of apoptosis

Authors: Gibb, RK Gercel-Taylor, C

Citation: Rk. Gibb et C. Gercel-taylor, Use of diphenylamine in the detection of apoptosis, METH MOL M, 39, 2000, pp. 679-680

Activation of caspase protease during apoptosis in ovarian cancer cells

Authors: Chen, ZH Naito, M Mashima, T Hiroyuki, S Tsuruo, T

Citation: Zh. Chen et al., Activation of caspase protease during apoptosis in ovarian cancer cells, METH MOL M, 39, 2000, pp. 681-685

Differential expression of apoptosis-associated genes bax and bcl-2 in ovarian cancer

Authors: Marx, D Meden, H

Citation: D. Marx et H. Meden, Differential expression of apoptosis-associated genes bax and bcl-2 in ovarian cancer, METH MOL M, 39, 2000, pp. 687-691

DNA-dependent protein kinase in apoptosis

Authors: Turchi, JJ

Citation: Jj. Turchi, DNA-dependent protein kinase in apoptosis, METH MOL M, 39, 2000, pp. 693-700

Detection of telomerase activity by PCR-based assay

Authors: Kyo, S

Citation: S. Kyo, Detection of telomerase activity by PCR-based assay, METH MOL M, 39, 2000, pp. 701-709

Immunological and gene therapy for ovarian cancer - A technical overview

Authors: Gourley, C Gabra, H

Citation: C. Gourley et H. Gabra, Immunological and gene therapy for ovarian cancer - A technical overview, METH MOL M, 39, 2000, pp. 713-728

Developing anti-HER2/neu single-chain Fv fragments from phage display libraries

Authors: Adams, GP Schier, R

Citation: Gp. Adams et R. Schier, Developing anti-HER2/neu single-chain Fv fragments from phage display libraries, METH MOL M, 39, 2000, pp. 729-747

Direction of the recognition specificity of cytotoxic T cells toward tumorcells by transduced, chimeric T-cell receptor genes

Authors: Maurer-Gebhard, M Azemar, M Altenschmidt, U Humar, M Groner, B

Citation: M. Maurer-gebhard et al., Direction of the recognition specificity of cytotoxic T cells toward tumorcells by transduced, chimeric T-cell receptor genes, METH MOL M, 39, 2000, pp. 749-756

Eradication of c-erbB-2-positive ovarian cancer cells mediated by intracellular expression of anti-c-erbB-2 antibody

Authors: Deshane, J Alvarez, RD Siegal, GP

Citation: J. Deshane et al., Eradication of c-erbB-2-positive ovarian cancer cells mediated by intracellular expression of anti-c-erbB-2 antibody, METH MOL M, 39, 2000, pp. 757-768

c-erbB-2 antisense oligonucleotides inhibit serum-induced cell spreading of ovarian cancer cells

Authors: Kai, WC

Citation: Wc. Kai, c-erbB-2 antisense oligonucleotides inhibit serum-induced cell spreading of ovarian cancer cells, METH MOL M, 39, 2000, pp. 769-774

E1A-mediated gene therapy

Authors: Hung, MC Yan, DH Zhang, S

Citation: Mc. Hung et al., E1A-mediated gene therapy, METH MOL M, 39, 2000, pp. 775-782

p53 adenovirus as gene therapy for ovarian cancer

Authors: Carroll, JL Mathis, JM Bell, MC Santoso, JT

Citation: Jl. Carroll et al., p53 adenovirus as gene therapy for ovarian cancer, METH MOL M, 39, 2000, pp. 783-792

Bispecific antibody MDX-210 for treatment of advanced ovarian and breast cancer

Authors: Kaufman, PA Wallace, PK Valone, FH Wells, WA Memoli, VA Ernstoff, MS

Citation: Pa. Kaufman et al., Bispecific antibody MDX-210 for treatment of advanced ovarian and breast cancer, METH MOL M, 39, 2000, pp. 793-806

Risultati: 1-25 | 26-50 | 51-75 | 76-89 |